Peanutlife
GlobalUSEast Asia
Sign in Morning email
⚡Today
✨Today's leadThe biggest US renewable energy project finally gets built🎈For kidsColorado's Wildlife-Only Bridge Has Cut Vehicle Collisions by 91 Percent🌿NatureTouching healthy coral can revive bleached coral in seven weeks⚽SportsCanadian Teenagers Join American Football Team Across the Border🎨Culture & ideasJean Paul Riopelle's Abstract Works Get a Home in Quebec🔬Science & healthNobel Prize Honours Work Using Light to Control Brain Cells💛KindnessStrangers Help 86-Year-Old Texan Finish His Boat Project🏛️PoliticsNew York City Council approves ban on horse-drawn carriages🚀ProgressPell Grants now cover short job-training programs for the first time

Personalized Cancer Vaccine Cuts Melanoma Recurrence Risk by 42 Percent

STAT 22 October 2026 2 min read Read and summarised by Claude, our robot with a library card. Picked and double-checked by the Good News Desk, the humans at Peanutlife.

⏮ BeforePatients with melanoma faced the risk of recurrence after standard treatment.
✅ NowIn the trial, a personalized mRNA vaccine reduced that recurrence risk by 42 percent.

In short

  • The personalized mRNA cancer vaccine was tested in patients with melanoma.
  • It reduced the risk of disease recurrence by 42 percent compared with standard treatment.
  • Detailed data were released confirming the trial met its key endpoints.

Why the Good News Desk likes this one

The vaccine is built around each patient's own tumour and is given alongside standard care. The 42 percent figure comes from a trial, so the result still needs to be confirmed in wider use. Detailed data now show the study met its main goals.

Advertisement

From STAT

A Moderna and Merck personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% compared to standard treatment.

Read the full story at STAT Opens the publisher's site in a new tab.

Ask this story

Answers come only from the material behind this story, with a link to the source.

Next in today's ten

6 🎨Culture & ideas

Jean Paul Riopelle's Abstract Works Get a Home in Quebec

Smithsonian · 2 min
7 🔬Science & health

A Living Drug Could Be First Treatment for Stiff Person Syndrome

Science News · 3 min
Advertisement
AdMobile anchor